The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis.

Dakik, Hassan K; Moskovic, Daniel J; Carlson, Peter J; Tamm, Eric P; Qiao, Wei; Wolff, Robert A; Abbruzzese, James L; Fogelman, David R

Dakik, Hassan K; Moskovic, Daniel J; Carlson, Peter J; Tamm, Eric P; Qiao, Wei; Wolff, Robert A; Abbruzzese, James L; Fogelman, David R.

Affiliation

Dakik HK; Duke University Medical Center, Durham, NC, USA.

Cancer Chemother Pharmacol ; 69(2): 425-30, 2012 Feb.

Article in En | MEDLINE | ID: mdl-21850466

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Pancreatic Neoplasms/drug therapy; Adult; Aged; Anemia/chemically induced; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Capecitabine; Deoxycytidine/administration & dosage; Deoxycytidine/adverse effects; Deoxycytidine/analogs & derivatives; Docetaxel; Female; Fluorouracil/administration & dosage; Fluorouracil/adverse effects; Fluorouracil/analogs & derivatives; Hospitalization/statistics & numerical data; Humans; Kaplan-Meier Estimate; Leukopenia/chemically induced; Male; Middle Aged; Neoplasm Metastasis; Outcome Assessment, Health Care/statistics & numerical data; Pancreatic Neoplasms/pathology; Retrospective Studies; Taxoids/administration & dosage; Taxoids/adverse effects; Thrombocytopenia/chemically induced; Treatment Failure; Gemcitabine

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2012 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google